164 related articles for article (PubMed ID: 20361930)
1. The frequency of KRAS mutation detection in human colon carcinoma is influenced by the sensitivity of assay methodology: a comparison between direct sequencing and real-time PCR.
Kobunai T; Watanabe T; Yamamoto Y; Eshima K
Biochem Biophys Res Commun; 2010 Apr; 395(1):158-62. PubMed ID: 20361930
[TBL] [Abstract][Full Text] [Related]
2. KRAS mutations in tumor tissue and plasma by different assays predict survival of patients with metastatic colorectal cancer.
Xu JM; Liu XJ; Ge FJ; Lin L; Wang Y; Sharma MR; Liu ZY; Tommasi S; Paradiso A
J Exp Clin Cancer Res; 2014 Dec; 33(1):104. PubMed ID: 25491325
[TBL] [Abstract][Full Text] [Related]
3. Comparison of PNA clamping and direct sequencing for detecting KRAS mutations in matched tumour tissue, cell block, pleural effusion and serum from patients with malignant pleural effusion.
Kang JY; Park CK; Yeo CD; Lee HY; Rhee CK; Kim SJ; Kim SC; Kim YK; Park MS; Yim HW
Respirology; 2015 Jan; 20(1):138-46. PubMed ID: 25302858
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of real-time PCR-optimized oligonucleotide probe method and Sanger sequencing for detection of KRAS mutations in colorectal and lung carcinomas].
Qiu T; Ling Y; Chen Z; Shan L; Guo L; Lü N; Ying JM
Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):599-602. PubMed ID: 23157827
[TBL] [Abstract][Full Text] [Related]
5. Detection of KRAS mutations in colorectal cancer with Fast COLD-PCR.
Carotenuto P; Roma C; Cozzolino S; Fenizia F; Rachiglio AM; Tatangelo F; Iannaccone A; Baron L; Botti G; Normanno N
Int J Oncol; 2012 Feb; 40(2):378-84. PubMed ID: 21971641
[TBL] [Abstract][Full Text] [Related]
6. KRAS gene mutation in a series of unselected colorectal carcinoma patients with prognostic morphological correlations: a pyrosequencing method improved by nested PCR.
de Macêdo MP; de Melo FM; Lisboa BC; Andrade LD; de Souza Begnami MD; Junior SA; Ribeiro HS; Soares FA; Carraro DM; da Cunha IW
Exp Mol Pathol; 2015 Jun; 98(3):563-7. PubMed ID: 25835782
[TBL] [Abstract][Full Text] [Related]
7. Usefulness of peptide nucleic acid (PNA)-clamp smart amplification process version 2 (SmartAmp2) for clinical diagnosis of KRAS codon 12 mutations in lung adenocarcinoma: comparison of PNA-clamp SmartAmp2 and PCR-related methods.
Araki T; Shimizu K; Nakamura K; Nakamura T; Mitani Y; Obayashi K; Fujita Y; Kakegawa S; Miyamae Y; Kaira K; Ishidao T; Lezhava A; Hayashizaki Y; Takeyoshi I; Yamamoto K
J Mol Diagn; 2010 Jan; 12(1):118-24. PubMed ID: 20007840
[TBL] [Abstract][Full Text] [Related]
8. Comparison of KRAS mutation tests in colorectal cancer patients.
Hancer VS; Buyukdogan M; Türkmen I; Bassullu N; Altug T; Diz-Kucukkaya R; Bulbul-Dogusoy G; Demir G
Genet Test Mol Biomarkers; 2011 Nov; 15(11):831-4. PubMed ID: 21699410
[TBL] [Abstract][Full Text] [Related]
9. Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach.
Carotenuto P; Roma C; Rachiglio AM; Tatangelo F; Pinto C; Ciardiello F; Nappi O; Iaffaioli RV; Botti G; Normanno N
Pharmacogenomics; 2010 Aug; 11(8):1169-79. PubMed ID: 20712532
[TBL] [Abstract][Full Text] [Related]
10. Rapid screening assay for KRAS mutations by the modified smart amplification process.
Tatsumi K; Mitani Y; Watanabe J; Takakura H; Hoshi K; Kawai Y; Kikuchi T; Kogo Y; Oguchi-Katayama A; Tomaru Y; Kanamori H; Baba M; Ishidao T; Usui K; Itoh M; Cizdziel PE; Lezhava A; Ueda M; Ichikawa Y; Endo I; Togo S; Shimada H; Hayashizaki Y
J Mol Diagn; 2008 Nov; 10(6):520-6. PubMed ID: 18832461
[TBL] [Abstract][Full Text] [Related]
11. Biased discordance of KRAS mutation detection in archived colorectal cancer specimens between the ARMS-Scorpion method and direct sequencing.
Bando H; Tsuchihara K; Yoshino T; Kojima M; Ogasawara N; Fukushima H; Ochiai A; Ohtsu A; Esumi H
Jpn J Clin Oncol; 2011 Feb; 41(2):239-44. PubMed ID: 21113056
[TBL] [Abstract][Full Text] [Related]
12. LNA-based PCR clamping enrichment assay for the identification of KRAS mutations.
Efrati E; Elkin H; Peerless Y; Sabo E; Ben-Izhak O; Hershkovitz D
Cancer Biomark; 2010-2011; 8(2):89-94. PubMed ID: 21896996
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of alterations in KRAS isoforms KRAS-4A/4B and KRAS mutations in colorectal carcinoma.
Abubaker J; Bavi P; Al-Haqawi W; Sultana M; Al-Harbi S; Al-Sanea N; Abduljabbar A; Ashari LH; Alhomoud S; Al-Dayel F; Uddin S; Al-Kuraya KS
J Pathol; 2009 Dec; 219(4):435-45. PubMed ID: 19824059
[TBL] [Abstract][Full Text] [Related]
14. High sensitive mutation analysis on KRAS gene using LNA/DNA chimeras as PCR amplification blockers of wild-type alleles.
Huang Q; Wang GY; Huang JF; Zhang B; Fu WL
Mol Cell Probes; 2010 Dec; 24(6):376-80. PubMed ID: 20732413
[TBL] [Abstract][Full Text] [Related]
15. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P
J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301
[TBL] [Abstract][Full Text] [Related]
16. Genetic analysis in APC, KRAS, and TP53 in patients with stomach and colon cancer.
Palacio-Rúa KA; Isaza-Jiménez LF; Ahumada-Rodríguez E; Muñetón-Peña CM
Rev Gastroenterol Mex; 2014; 79(2):79-89. PubMed ID: 24861525
[TBL] [Abstract][Full Text] [Related]
17. Low frequency of KRAS mutation in pancreatic ductal adenocarcinomas in Korean patients and its prognostic value.
Kwon MJ; Jeon JY; Park HR; Nam ES; Cho SJ; Shin HS; Kwon JH; Kim JS; Han B; Kim DH; Choi YL
Pancreas; 2015 Apr; 44(3):484-92. PubMed ID: 25513781
[TBL] [Abstract][Full Text] [Related]
18. A commercial real-time PCR kit provides greater sensitivity than direct sequencing to detect KRAS mutations: a morphology-based approach in colorectal carcinoma.
Angulo B; García-García E; Martínez R; Suárez-Gauthier A; Conde E; Hidalgo M; López-Ríos F
J Mol Diagn; 2010 May; 12(3):292-9. PubMed ID: 20203003
[TBL] [Abstract][Full Text] [Related]
19. KRAS mutation detection in Tunisian sporadic coloractal cancer patients with direct sequencing, high resolution melting and denaturating high performance liquid chromatography.
Karim B; Florence C; Kamel R; Nadia K; Ines O; Raja M; Sarra BJ; Florent S; Amel BA
Cancer Biomark; 2010-2011; 8(6):331-40. PubMed ID: 22072121
[TBL] [Abstract][Full Text] [Related]
20. KRAS mutation: comparison of testing methods and tissue sampling techniques in colon cancer.
Franklin WA; Haney J; Sugita M; Bemis L; Jimeno A; Messersmith WA
J Mol Diagn; 2010 Jan; 12(1):43-50. PubMed ID: 20007845
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]